2AJ3
Crystal Structure of a Cross-Reactive HIV-1 Neutralizing CD4-Binding Site Antibody Fab m18
2AJ3 の概要
エントリーDOI | 10.2210/pdb2aj3/pdb |
関連するPDBエントリー | 1HZH 1RHH |
分子名称 | Fab m18, Light Chain, Fab m18, Heavy Chain, SULFATE ION, ... (4 entities in total) |
機能のキーワード | hiv, antibody, fab, cd4-binding, immunoglobulin, immune system |
由来する生物種 | Homo sapiens (human) 詳細 |
タンパク質・核酸の鎖数 | 6 |
化学式量合計 | 143881.33 |
構造登録者 | Prabakaran, P.,Gan, J.,Wu, Y.Q.,Zhang, M.Y.,Dimitrov, D.S.,Ji, X. (登録日: 2005-08-01, 公開日: 2006-03-28, 最終更新日: 2024-10-30) |
主引用文献 | Prabakaran, P.,Gan, J.,Wu, Y.Q.,Zhang, M.Y.,Dimitrov, D.S.,Ji, X. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs. J.Mol.Biol., 357:82-99, 2006 Cited by PubMed Abstract: Human immunodeficiency virus (HIV) entry into cells is initiated by the binding of its envelope glycoprotein (Env) gp120 to receptor CD4. Antibodies that bind to epitopes overlapping the CD4-binding site (CD4bs) on gp120 can prevent HIV entry by competing with cell-associated CD4; their ability to outcompete CD4 is a major determinant of their neutralizing potency and is proportional to their avidity. The breadth of neutralization and the likelihood of the emergence of antibody-resistant virus are critically dependent on the structure of their epitopes. Because CD4bs is highly conserved, it is reasonable to hypothesize that antibodies closely mimicking CD4 could exhibit relatively broad cross-reactivity and a high probability of preventing the emergence of resistant viruses. Previously, in a search for antibodies that mimic CD4 or the co-receptor, we identified and characterized a broadly cross-reactive HIV-neutralizing CD4bs human monoclonal antibody (hmAb), m18. Here, we describe the crystal structure of Fab m18 at 2.03 A resolution, which reveals unique conformations of heavy chain complementarity-determining regions (CDRs) 2 and 3 (H2 and H3). H2 is highly bulged and lacks cross-linking interstrand hydrogen bonds observed in all four canonical structures. H3 is 17.5 A long and rigid, forming an extended beta-sheet decorated with an alpha-turn motif bearing a phenylalanine-isoleucine fork at the apex. It shows striking similarity to the Ig CDR2-like C'C'' region of the CD4 first domain D1 that dominates the binding of CD4 to gp120. Docking simulations suggest significant similarity between the m18 epitope and the CD4bs on gp120. Fab m18 does not enhance binding of CD4-induced (CD4i) antibodies, nor does it induce CD4-independent fusion mediated by the HIV Env. Thus, vaccine immunogens based on the m18 epitope structure are unlikely to elicit antibodies that could enhance infection. The structure can also serve as a basis for the design of novel, highly efficient inhibitors of HIV entry. PubMed: 16426633DOI: 10.1016/j.jmb.2005.12.062 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.03 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード